Lemonade From Lemons: Boston Scientific CEO On The Changes At Guidant
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's makeover of Guidant is "not rocket science," but "adds up to a major cultural shift" at the recently acquired subsidiary, said Boston Scientific CEO Jim Tobin
You may also be interested in...
Boston Scientific: Tobin Broadens Horizons, LaViolette To Leave
Boston Scientific CEO Jim Tobin will begin managing day-to-day operations across the company now that the firm's cardiac rhythm management business is stabilized, the firm said June 3
Boston Scientific: Tobin Broadens Horizons, LaViolette To Leave
Boston Scientific CEO Jim Tobin will begin managing day-to-day operations across the company now that the firm's cardiac rhythm management business is stabilized, the firm said June 3
St. Jude, Boston Scientific ICD Sales Growth Flat-Lines In Q3 – Rebound In ’07?
St. Jude Medical is more than halfway through a planned 500-rep expansion of its U.S. implantable cardioverter defibrillator sales force as part of its broader effort to reignite ICD sales growth